Advertisement

Odontology

, Volume 103, Issue 2, pp 203–209 | Cite as

Evaluation of serum anti-cardiolipin antibodies after non-surgical periodontal treatment in chronic periodontitis patients

  • Farin Kiany
  • Azita Hedayati
Original Article

Abstract

The present study investigated the effect of non-surgical periodontal therapy on serum level of anti-cardiolipin antibodies (aCLA), which are potentially involved in the pathogenesis of cardiovascular diseases in periodontal patients. Twenty volunteers (11 females and 9 males) with the mean age of 40.55 years participated in this study. Generalized chronic periodontitis was diagnosed through clinical periodontal examination at baseline visit. This examination included measuring the probing pocket depth and clinical attachment loss. Plaque index and gingival index were also recorded. After baseline examination, all the subjects received full-mouth non-surgical periodontal treatment. Subjects returned for a final visit 6 weeks after the last session of scaling for reevaluation of the periodontal parameters. At baseline and final visits 2 ml of venous blood was collected from each patient and an available commercially enzyme-linked immunosorbent assay was used for analyzing aCLA (IgM and IgG). The collected data were analyzed using the paired sample t test. Mean levels of both forms of aCLA, before and after treatment, showed statistically significant difference (P = 0.003 for IgM and P = 0.001 for IgG). In addition, study results showed significant reductions in periodontal parameters after non-surgical periodontal therapy (P < 0.001). The results of this study suggested that successful periodontal therapy can improve the serum level of one of the inflammatory biomarkers involved in the cardiovascular problems.

Keywords

Anti-cardiolipin antibodies Chronic periodontitis Cardiovascular diseases Antiphospholipid syndrome Periodontal treatment 

Notes

Acknowledgments

The authors thank the Vice-Chancellery of Shiraz University of Medical Sciences for supporting this research (Grant #3826). This manuscript is based on the thesis of Dr. Azita Hedayati. The authors would like to thank Dr. Shahram Hamedani (DDS, MSc) from the Dental Research Development Center and Dr. Ehya Amal saleh for editorial suggestions and English writing assistance and Dr. Mehrdad Vossoughi for the statistical analysis.

Conflict of interest

The authors declare they have no conflict of interest. No other funding, except that of the institution of the authors, was provided.

References

  1. 1.
    Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012;125(20):2520–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol. 2013;84(4 Suppl):S51–69.PubMedGoogle Scholar
  3. 3.
    Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol. 2004;31:25–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, James Beck, Gordon Douglass, Roy Page. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91(10):914–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Oliver RC, Brown LG, Löe H. Periodontal diseases in the United States population. J Periodontol. 1998;62:269–78.CrossRefGoogle Scholar
  6. 6.
    Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol. 2001;6:9–15.PubMedCrossRefGoogle Scholar
  7. 7.
    Jeffcoat MK, Geurs NC, Reddy MS, Goldenberg RL, Hauth JC. Current evidence regarding periodontal disease as a risk factor in preterm birth. Ann Periodontol. 2001;6:183–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Arbes SJ Jr, Slade GD Jr, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res. 1999;78:1777–82.PubMedCrossRefGoogle Scholar
  9. 9.
    Madden IM, Stock CA, Holt RD, Bidinger PD, Newman HN. Oral health status and access to care in a rural area of India. J Int Acad Periodontol. 2000;2:110–4.PubMedGoogle Scholar
  10. 10.
    Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun. 2000;15:145–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752–63.PubMedCrossRefGoogle Scholar
  12. 12.
    Scannapieco FA. Position paper of The American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases. J Periodontol. 1998;69(7):841–50.PubMedGoogle Scholar
  13. 13.
    Joshipura K. The relationship between oral conditions and ischemic stroke and peripheral vascular disease. J Am Dent Assoc. 2002;133(Suppl):23S–30S.PubMedCrossRefGoogle Scholar
  14. 14.
    Kandiah DA, Krilis SA. Beta 2-glycoprotein I. Lupus. 1994;3(4):207–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Karnoutsos K, Papastergiou P, Stefanidis S, Vakaloudi A. Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anticardiolipin antibodies. Hippokratia. 2008;12:144–9.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Kobayashi K, Lopez LR, Shoenfield Y, Matsuura E. The role of innate and adaptive immunity to oxidized low-density lipo-protein in the development of atherosclerosis. Ann N Y Acad Sci. 2005;1051:442–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Chen YW, Nagasawa T, Wara-Aswapati N, Ushida Y, Wang D, Takeuchi Y, Kobayashi H, Umeda M, Inoue Y, Iwai T, Ishikawa I, Izumi Y. Association between periodontitis and anti-cardiolipin antibodies in Buerger disease. J Clin Periodontol. 2009;36(10):830–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Rozee KR, Acott P, Lee SH, Crocker JF, Gough D, MacDonald J, Evans J, Murphy MG. Elevated anticardiolipin antibodies in acute liver failure. Biochim Biophys Acta. 2003;1637(3):183–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Schenkein HA, Berry CR, Burmeister JA, Brooks CN, Barbour SE, Best AM, Tew JG. Anti-cardiolipin antibodies in sera from patients with periodontitis. J Dent Res. 2003;82(11):919–22.PubMedCrossRefGoogle Scholar
  20. 20.
    Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol. 1997;17:3159–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Locht H, Wiik A. IgG and IgM isotypes of anticardiolipin and anti-b2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events. Clin Rheumatol. 2006;25:246–50.PubMedCrossRefGoogle Scholar
  22. 22.
    Türkoğlu O, Barisx N, Kütükcxüler N, Senarslan O, Güneri S, Atilla G. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. J Periodontol. 2008;79:332–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Paquette DW, Brodala N, Nichols TC. Cardiovascular disease, inflammation, and periodontal infection. Periodontology. 2000;2007(44):113–26.Google Scholar
  24. 24.
    Gunupati S, Chava VK, Krishna BP. Effect of phase I periodontal therapy on anti-cardiolipin antibodies in patients with acute myocardial infarction associated with chronic periodontitis. J Periodontol. 2011;82(12):1657–64.PubMedCrossRefGoogle Scholar
  25. 25.
    Schenkein HA, Best AM, Brooks CN, Burmeister JA, Arrowood JA, Kontos MC, Tew JG. Anti-cardiolipin and increased serum adhesion molecule levels in patients with aggressive periodontitis. J Periodontol. 2007;78(3):459–66.PubMedCrossRefGoogle Scholar
  26. 26.
    Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–35.PubMedCrossRefGoogle Scholar
  27. 27.
    Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–51.PubMedCrossRefGoogle Scholar
  28. 28.
    Flemming TF. Periodontitis. Ann Periodontol. 1999;4(1):32–8.CrossRefGoogle Scholar
  29. 29.
    Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol. 2003;8(1):38–53.PubMedCrossRefGoogle Scholar
  30. 30.
    Holmlund A, Holm G, Lind L. Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. J Periodontol. 2006;77(7):1173–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Elter JR, Champagne CM, Offenbacher S, Beck JD. Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease. J Periodontol. 2004;75:782–90.PubMedCrossRefGoogle Scholar
  32. 32.
    Karhunen V, Forss H, Goebeler S, Huhtala H, Ilveskoski E, Kajander O, Mikkelsson J, Penttilä A, Perola M, Ranta H, Meurman JH, Karhunen PJ. Radiographic assessment of dental health in middle-aged men following sudden cardiac death. J Dent Res. 2006;85(1):89–93.PubMedCrossRefGoogle Scholar
  33. 33.
    Dietrich T, Jimenez M, Krall Kaye EA, Vokonas PS, Garcia RI. Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation. 2008;117:1668–74.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43.PubMedCrossRefGoogle Scholar
  35. 35.
    Glurich I, Grossi S, Albini B, Ho A, Shah R, Zeid M, Baumann H, Genco RJ, De Nardin E. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol. 2002;9(2):425–32.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Geerts SO, Nys M, De MP, Charpentier J, Albert A, Legrand V, Rompen EH. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002;73(1):73–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: a risk factor for coronary heart disease? Ann Periodontol. 1998;3(1):127–41.PubMedCrossRefGoogle Scholar
  38. 38.
    Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology. 1990;40(8):1190–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, Barbui T, Zwaal RF, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335(8705):1544–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Roubey RA, Pratt CW, Buyon JP, Winfield JB. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J Clin Invest. 1992;90(3):1100–4.PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002;109(6):797–804.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Blank M, Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol. 2004;112(2):190–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Faghihi SH, Rokn AR, Ebrahimi R. Evaluation of serum anti-cardiolipin antibody titer of patients with chronic periodontitis in comparison with periodontally healthy population. J Dent Tehran Univ Med Sci. 2009;6(2):1–6.Google Scholar
  44. 44.
    Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, Murayama Y. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol. 2003;74(8):1231–6.PubMedCrossRefGoogle Scholar
  45. 45.
    D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005;84(3):269–73.PubMedCrossRefGoogle Scholar
  46. 46.
    Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V, Asikainen S. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis. 2002;2:30.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Ide M, Jagdev D, Coward PY, Crook M, Barclay GR, Wilson RF. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol. 2004;75(3):420–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N, Madianos PN. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J. 2006;151(1):47.PubMedCrossRefGoogle Scholar
  49. 49.
    Taylor BA, Tofler GH, Carey HM, Morel-Kopp MC, Philcox S, Carter TR, Elliott MJ, Kull AD, Ward C, Schenck K. Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J Dent Res. 2006;85(1):74–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, Bratschko RO, Pilger E. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J. 2005;149:1050–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Amoroso A, Mitterhofer AP, Porto FD, Garzia P, Ferri GM, Galluzzo S, Vadacca M, Caccavo D, Afeltra A. Antibodies to anionic phospholipids and anti-β2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Hum Immunol. 2003;64:256–73.CrossRefGoogle Scholar
  52. 52.
    Hussain SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M. Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. J Periodontol. 2009;80(10):1574–80.CrossRefGoogle Scholar

Copyright information

© The Society of The Nippon Dental University 2014

Authors and Affiliations

  1. 1.Oral and Dental Health Care Research CenterShiraz University of Medical SciencesShirazIran
  2. 2.Department of Periodontics, School of DentistryShiraz University of Medical SciencesShirazIran

Personalised recommendations